XBiotech Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 92

Employees

  • Stock Symbol
  • XBIT

Stock Symbol

  • Share Price
  • $6.10
  • (As of Friday Closing)

XBiotech General Information

Description

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
NAS
Corporate Office
  • 5217 Winnebago Lane
  • Austin, TX 78744
  • United States
+1 (512) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XBiotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.10 $6.32 $3.51 - $9.96 $186M 30.5M 81.5K -$1.02

XBiotech Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 47,430 (80,443) (113,258) 99,467
Revenue 0 0 4,010 18,394
EBITDA (39,004) (32,990) (34,797) (23,277)
Net Income (30,743) (24,557) (32,900) (17,414)
Total Assets 227,858 226,615 246,103 275,177
Total Debt 10,000 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

XBiotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore XBiotech‘s full profile, request access.

Request a free trial

XBiotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and develop
Biotechnology
Austin, TX
92 As of 2024
0000
00000 0000-00-00
00000000 0000

000000

illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000 000000000
Watertown, MA
000 As of 0000
00000
00000000 00000

00000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000 000000000
London, United Kingdom
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XBiotech Competitors (129)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EyePoint Pharmaceuticals Corporation Watertown, MA 000 00000 00000000 00000
Akari Therapeutics Formerly VC-backed London, United Kingdom 00 00000 000000000 00000
Strongbridge Biopharma Corporate Backed or Acquired Trevose, PA 00 00000 000000&0 00000
Astex Pharmaceuticals Corporate Backed or Acquired Cambridge, United Kingdom 00 00000 000000&0 00000
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
You’re viewing 5 of 129 competitors. Get the full list »

XBiotech Patents

XBiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3095676-A1 True human antibody specific for interleukin 1 alpha (il-1a) Pending 07-Oct-2020 0000000000
CA-3095675-A1 True human antibody specific for interleukin 1 alpha (il-1a) Pending 07-Oct-2020 0000000000
CA-3095740-A1 True human antibody specific for interleukin alpha (il-1a) Pending 07-Oct-2020 0000000000
CA-3095679-A1 True human antibody specific for interleuken 1 alpha (il-1a) Pending 07-Oct-2020 000000000
AU-2021356341-A1 True human antibody specific for interleukin 1 alpha (il-1α) Pending 07-Oct-2020 A61P29/00
To view XBiotech’s complete patent history, request access »

XBiotech Executive Team (7)

Name Title Board Seat Contact Info
John Simard Founder, President, Chief Executive Officer & Chairman
Martin Schmieg Chief Financial Officer
Sushma Shivaswamy Chief Scientific Officer
Benjamin Guzman Senior Vice President of Corporate Strategy, Financial & Management
Anthony Johnston Vice President, Corporate Development
You’re viewing 5 of 7 executive team members. Get the full list »

XBiotech Board Members (1)

Name Representing Role Since
0000 000000 XBiotech Founder, President, Chief Executive Officer & Chairman 000 0000
To view XBiotech’s complete board members history, request access »

XBiotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XBiotech ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

32.09 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 14,912

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 965

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 443

Rank

00.00

Percentile

To view XBiotech’s complete esg history, request access »

XBiotech FAQs

  • When was XBiotech founded?

    XBiotech was founded in 2005.

  • Who is the founder of XBiotech?

    John Simard is the founder of XBiotech.

  • Who is the CEO of XBiotech?

    John Simard is the CEO of XBiotech.

  • Where is XBiotech headquartered?

    XBiotech is headquartered in Austin, TX.

  • What is the size of XBiotech?

    XBiotech has 92 total employees.

  • What industry is XBiotech in?

    XBiotech’s primary industry is Biotechnology.

  • Is XBiotech a private or public company?

    XBiotech is a Public company.

  • What is XBiotech’s stock symbol?

    The ticker symbol for XBiotech is XBIT.

  • What is the current stock price of XBiotech?

    As of 14-Jun-2024 the stock price of XBiotech is $6.10.

  • What is the current market cap of XBiotech?

    The current market capitalization of XBiotech is $186M.

  • Who are XBiotech’s competitors?

    EyePoint Pharmaceuticals, Akari Therapeutics, Strongbridge Biopharma, Astex Pharmaceuticals, and Inovio Pharmaceuticals are some of the 129 competitors of XBiotech.

  • What is XBiotech’s annual earnings per share (EPS)?

    XBiotech’s EPS for 12 months was -$1.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »